Mednow Launches New Virtual Diabetes Management Program in Partnership With Dexcom
Diabetes imposes a heavy economic burden on both the global healthcare system and wider global economy. According to WHO, the global cost is estimated to be 825 billion US dollars per year, and is mostly driven by the costs of diabetes complications. Yet, so far, there is still an unmet need for research into the health of people living with diabetes to improve their quality of life & disease management, and prevent them from developing diabetes-related complications and premature mortality. Furthermore, digital medicine, digital research and artificial intelligence (AI) have the power to transform the field of diabetes with continuous and no-burden remote monitoring of patients’ symptoms, physiological data, behaviors and environmental contexts through the use of wearable’s, sensors and smartphone technologies. In addition, digital technologies and electronic healthcare, represent a major opportunity to rethink diabetes, as they are expected to have a major impact on all aspects of diabetes, from prevention to research, including diabetes care and management.
To know
the scope of our report get a sample on https://www.axiommrc.com/request-for-sample/10114-digital-diabetes-management-market-report
DIGITAL DIABETES MANAGEMENT MARKET OUTLOOK
The global digital diabetes management
market is driven by key factors such as increasing prevalence of diabetes,
increasing penetration of digital platforms and advancement in technology.
However, high cost of devices and lack of reimbursement in developing countries
is one of the factor hampering the market growth.
DIGITAL DIABETES MANAGEMENT MARKET
SEGMENTAL OVERVIEW
The digital
diabetes management market is segmented by product & service, device
type, end user and geography
DIGITAL DIABETES MANAGEMENT MARKET BY
PRODUCT & SERVICE
The products & services in this report
are devices, digital diabetes management apps, data management software and
platforms and services. The devices segments is further bifurcated into smart
glucose meters, continuous glucose monitoring systems, smart insulin pens and
smart insulin pumps & smart insulin patches. Furthermore, digital diabetes
management apps are classified into diabetes & blood glucose tracking apps
and weight & diet management apps. The growing demand for wireless and
wearable devices for diabetes management, growing acceptance of smart insulin
pumps & pens for insulin delivery, technological innovations in devices are
the key factors driving the devices segment globally.
Some More...https://vherso.com/read-blog/12863
DIGITAL DIABETES MANAGEMENT MARKET BY
DEVICE TYPE
Based on type, the digital diabetes
management market is segmented into wearable devices and handheld devices. The
increasing number of regulatory approvals for CGM systems, technological
advancements such as closed-loop pump systems, smart insulin patches, and other
pipeline devices are attributing the growth of wearable devices segment
globally.
DIGITAL DIABETES MANAGEMENT MARKET BY END
USER
The various end user studied in this report
are self/home healthcare, hospitals & specialty diabetes clinics and
academic & research institutes. The self/home healthcare segment dominated
the market in 2018, due to the move toward home care & self-management of
diabetes and advancement in technology.
DIGITAL DIABETES MANAGEMENT MARKET BY
GEOGRAPHY
On the basis of geography, the digital
diabetes management market is segmented into North America, Europe,
Asia-Pacific and Rest of the world.
North America region dominated the digital diabetes management market in
2018 due to advancement in technology solutions, high adoption of remote online
coaching services for diabetes management and favorable reimbursement policies.
DIGITAL DIABETES MANAGEMENT MARKET KEY
PLAYERS
Some of the major players operating in the
digital diabetes management market includes Medtronic PLC, F. Hoffmann-La Roche,
Dexcom, Inc., Ascensia Diabetes Care Holdings Ag., Abbott Laboratories, B.
Braun Melsungen AG, Tidepool, Glooko, Inc., Lifescan, Inc. (A Subsidiary of
Johnson & Johnson), Agamatrix, Inc., Tandem Diabetes Care, Inc., Insulet
Corporation and Dariohealth Corporation. Leading companies have invested
massive capital in research & development and mergers & acquisitions
activities to develop innovative products in the market.
DIGITAL DIABETES MANAGEMENT MARKET
DEVELOPMENTS
November 2018: Medtronic plc acquired
Nutrino Health Ltd. (Israel). This acquisition strengthened Metronic’s CGM and
industry-leading hybrid closed-loop systems portfolio in the digital diabetes
management market.
November 2018: Roche announced its
partnership with the digital therapeutic company Wellthy Therapeutics to offer
users of the Accu-Chek Active system, a clinically validated artificial
intelligence-based digital diabetes coaching solution.
June 2018: Medtronic plc, the global leader
in medical technology, announced the launch of the MiniMed(TM) 670G Performance
Guarantee Program - an outcomes-based offering for payers and employers
designed to mitigate costs for diabetes-related complications.
Buy now Digital Diabetes Management Market
Report https://www.axiommrc.com/buy_now/10114-digital-diabetes-management-market-report
Comments
Post a Comment